James Frates
Chief Financial Officer
CFO
CFO
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $540,600 | $1,375,327 |
| 2024 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $540,600 | $2,540,353 |
| 2023 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $510,000 | $3,510,377 |
| 2022 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $439,500 | $3,658,945 |
| 2021 | Amylyx Pharmaceuticals, Inc. (AMLX) | Chief Financial Officer | $375,000 | $3,255,900 |
Earnings-call appearances
-
Amylyx Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-05-07
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-06
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-07
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-04
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-07
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-08
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-09
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-05-11
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-03-13
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Amylyx Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-10
Amylyx Pharmaceuticals, Inc. (AMLX)
-
Alkermes plc. Q2 FY2020 Earnings Call2020-07-29
Alkermes plc. (ALKS)
-
Alkermes plc. Q1 FY2020 Earnings Call2020-04-29
Alkermes plc. (ALKS)